Richard Hughes | Principal
Avalere Health Llc

Richard Hughes, Principal, Avalere Health Llc

Richard Hughes IV, J.D., M.P.H., Principal and Avalere Vaccines Team Leader advises vaccine manufacturers on vaccine market shaping strategy, policy, finance, coverage, reimbursement and access. A nationally and industry recognized public health thought leader, Richard has led efforts to reform US vaccine coverage, expand vaccine access and enact policies that increase vaccine uptake and protect against vaccine market threats.

Prior to joining Avalere, Richard practiced with a Washington health law firm, advising major vaccine manufacturers, providers and health insurance plans. His previous roles include Associate Director of Policy with the Merck Vaccine Division, Director of State Health Policy and Immunization Policy with the Association of State and Territorial Health Officials, and gubernatorial appointee to the Arkansas State Board of Health. Richard previously held an academic faculty appointment as a Professorial Lecturer in Health Policy & Management at The George Washington University’s Milken Institute School of Public Health. He earned his JD from The George Washington University Law School and MPH from the University of Arkansas for Medical Sciences. During law school, he proudly served as research assistant to renowned health law and vaccines scholar Professor Sara Rosenbaum. He is a member of the National Delta Omega Honorary Society in Public Health and the District of Columbia Bar.


Pre-congress Workshops, April 6 @ 10:00


Workshop: Market access & regulatory challenges in vaccines The market access landscape for vaccines is more complex than most. Various obstacles are creating a disproportionate move away from investing in preventative interventions and vaccines.Learn how get optimal value for our vaccines and avoid the pit falls when launching a new vaccine. Topics: Panel Discussion: Older Adult Immunization Uptake: Understanding Barriers and Drivers
  • Vaccine Preventable Disease in the Medicare Population
  • Vaccine Uptake and Cost-Sharing in the Medicare Population
  • Role of Quality in Driving Vaccine Uptake
Panel Discussion: The Vaccine Pipeline and the Role of Real-World Evidence
  • Vaccine Pipeline
  • The Evolving Role of the Real-World Evidence
  • Capturing the Full Value of Vaccines
  • Novel Candidates and the Role of the ACIP
last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates